NZP-27128-98755
2 vaccinations
3 coded responses
14 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 300 / GA
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-26
Dose 1 — Pfizer-BioNTech
-
2021-02-28
Registered in v-safe
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-04
- 2021-03-07
- 2021-03-12
-
2021-03-19
Dose 2 — Pfizer-BioNTech
- 2021-03-26
- 2021-04-02
- 2021-04-11
-
2021-04-16
Survey response — day 28, dose 2MedDRA: Asthma, Pre-existing disease — Feeling: GoodFree text: Asthma issues - could be related to allergies.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Survey response — day 35, dose 2MedDRA: Asthma, Pre-existing disease — Feeling: FairFree text: Astmha relatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-30
-
2021-06-18
Survey response — 3 months, dose 2MedDRA: Dyspnoea, Gastrooesophageal reflux disease, Headache, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Shortness of breath, asthma symptoms, headaches, acid refluxMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-18
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-22
- 2022-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Pfizer-BioNTech | |
| 2 | 2021-03-19 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — day 28, dose 2
Symptoms: Asthma issues - could be related to allergies.
Release 7 — day 35, dose 2
Symptoms: Astmha related
Release 9 — 3 months, dose 2
Symptoms: Shortness of breath, asthma symptoms, headaches, acid reflux
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Gastrooesophageal reflux disease | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release